<p>Explore the basis for and controversy surrounding the US Food and Drug Administration requiring a Risk Evaluation and Mitigation Strategy (REMS) for mifepristone. Full text of the manuscript is available at: https://accpjournals.onlinelibrary.wiley.com/doi/10.1002/jac5.2034. </p>

Explore the basis for and controversy surrounding the US Food and Drug Administration requiring a Risk Evaluation and Mitigation Strategy (REMS) for mifepristone. Full text of the manuscript is available at: https://accpjournals.onlinelibrary.wiley.com/doi/10.1002/jac5.2034.

Should the FDA be requiring a Risk Evaluation and Mitigation Strategy for mifepristone? - Ep 147

This podcast brings you interviews with journal authors providing insight on their recent publication in an official journal of the American College of Clinical Pharmacy. Pharmacotherapy publishes advances in human pharmacology and drug therapy and the JACCP publishes innovations in clinical pharmacy practice.
ACCP JOURNALS DISCLAIM ANY AND ALL LIABILITY OR RESPONSIBILITY FOR ANY DIRECT, INDIRECT, INCIDENTAL, SPECIAL, CONSEQUENTIAL, OR ANY OTHER DAMAGES, INCLUDING LOSS OF PROFITS, ARISING OUT OF ANY USE OF, REFERENCE TO, RELIANCE ON, OR INABILITY TO USE THE PODCAST, ITS CONTENTS AND MATERIALS.

Medicine

Health & Fitness

This podcast brings you interviews with journal authors providing insight on their recent publication in an official journal of the American College of Clinical Pharmacy. Pharmacotherapy publishes advances in human pharmacology and drug therapy and the JACCP publishes innovations in clinical pharmacy practice. ACCP JOURNALS DISCLAIM ANY AND ALL LIABILITY OR RESPONSIBILITY FOR ANY DIRECT, INDIRECT, INCIDENTAL, SPECIAL, CONSEQUENTIAL, OR ANY OTHER DAMAGES, INCLUDING LOSS OF PROFITS, ARISING OUT OF ANY USE OF, REFERENCE TO, RELIANCE ON, OR INABILITY TO USE THE PODCAST, ITS CONTENTS AND MATERIALS.

Share Should the FDA be requiring a Risk Evaluation and Mitigation Strategy for mifepristone? - Ep 147

Sign up to save your podcasts

Should the FDA be requiring a Risk Evaluation and Mitigation Strategy for mifepristone? - Ep 147

Should the FDA be requiring a Risk Evaluation and Mitigation Strategy for mifepristone? - Ep 147

More shows like ACCP JOURNALS

NEJM This Week

Diabetes Core Update

JACC This Week

JAMA Clinical Reviews

The Curbsiders Internal Medicine Podcast

Emergency Medical Minute

Core IM | Internal Medicine Podcast

Real Life Pharmacology - Pharmacology Education for Health Care Professionals

Annals On Call Podcast

Breakpoints

Run the List

Critical Care Scenarios

Febrile

Good Inside with Dr. Becky

Critical Care Time